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THE selectin-mediated rolling of leukocytes along
the endothelial cells is a prerequisite step fol-
lowed by firm adhesion and extravasation into
the inflamed tissue. This initial contact can be
suppressed by sulphated polysaccharides. We
have studied the effect of sulphated polysacchar-
ides on the ultimate polymorphonuclear leuko-
cyte (PMN) recruitment and plasma leakage in
rabbit skin in response to intradermal injection
of various inflammatory mediators. PMN infiltra-
tion evoked by various PMN chemoattractants
(FMLP, C5a desArg, LTB4 and IL-8) was signifi-
cantly inhibited after intravenous injection of
dextran sulphate (25 mg/kg), heparin (2 x 90 mg/
kg) or fucoidan (1 mg/kg). PMN-dependent plas-
ma leakage was equally well reduced by the
different sulphated polymers. Vascular permeabil-
ity induced by histamine or thrombin acting via a
PMN-independent mechanism was not reduced.
Fucoidan was the only polysaccharide able to
suppress IL-l-induced PMN infiltration for 60-
70%. Local administration of dextran sulphate
had no effect on PMN-dependent plasma leakage.
Differential inhibition of PMN recruitment was
determined after injection of dextran sulphate or
fucoidan depending on the type of insult. There-
fore, these results suggest that different adhesion
pathways are utilized during PMN recruitment in
vivo in response to chemoattractants and IL-1.
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Introduction
An inflammatory reaction (e.g. adult respiratory
distress syndrome, ischaemic reperfusion injury
or arthritis) is characterized by leukocyte emi-
gration and plasma protein leakage from the
blood stream into the extravascular injured
tissue. Leukocyte recruitment is designed as a
multistep process in which several types of cell
adhesion molecules are involved.1’2 The initial
contact of leukocytes with postcapillary en-
dothelial cells, described as rolling, is mediated
by the selectin family of adhesion molecules.3’4
The subsequent firm adhesion and transmi-
gration through the endothelial cell lining into
the inflamed tissue is mediated by leukocyte
fi2-integrins (CD11/CD18) and endothelial
immunoglobulin-like molecules (ICAM-1 and
PECAM-1).
5-7
The selectin family consists of three closely
related cell surface molecules: L-selectin
(CD62L, MEL-14, LAM-1), P-selectin (CD62P,
GMP-140) and E-selectin (CD62E, EIAM-1). L-
selectin, originally described as a lymphocyte
homing receptor (MEL-14)
8 is constitutively
present on PMNs, monocytes and most of the
lymphocytes. PMN activation results in a rapid
removal of L-selectin from the cell surface
9 (shedding). P-selectin normally exists pre-
formed in a-granules of platelets and in Weibel-
Palade bodies of endothelial cells. After stimula-
tion with histamine, thrombin or oxygen radi-
cals P-selectin is mobilized within minutes on
the endothelial cell surface.
1 E-selectin is ex-
pressed on endothelial cells via de novo mRNA
and protein synthesis after stimulation with
various inflammatory agents, i.e. LPS, IL-1 and
TNE
11 In vitro and in vivo studies have shown
that leukocyte L-selectin as well as endothelial
P- and E-selectin are involved in leukocyte
rolling supporting the final leukocyte re-
cruitment.9,12-15
346 Mediators of Inflammation Vol 5 1996 (C) 1996 Rapid Science PublishersSulphatedpolymers andPMN extravasation
A common characteristic for the three selec- Material and Methods
tins is their weak binding via their extracellular Animals Ca2+-dependent (C-type) lectin domain to sialy-
lated, fucosylated carbohydrates, like the tetra- Male New Zealand White rabbits (2.5-3.5 kg
saccharide sialyl Lewis X (SLeX).
6 Nevertheless body weight)were purchased from Penet Farm,
high affinity glycoprotein ligands for all three Moorsel, Belgium.
selectins have been described.4 This suggests
that in vivo each selectin preferentially inter- Reagents acts with its specific ligand(s). A mucin-like P-
selectin glycoprotein ligand (PSGL-1) and a Calcitonin gene-related peptide (CGRP), cyto-
fibroblas growth factor-related E-selectin ligand chalasin B (Cyt B), Evans blue dye, FMLP and 2-
(ESL-1) are described on endothelial cells,lv’8 mercapto pyridine-N-oxide (MERe) were pur-
Various ligands for L-selectin are described, chased from Sigma, Chemical Co. (St Louis, MO,
depending on the type of endothelial cells: the USA). Thrombin (Thr)(Topostasine(R)) was from
sulphated glycoproteins Sgp50 (GlyCAM-1) and Hoffmann-La Roche (Basel, Switzerland).
Sgp90 (identical to the sialomucin CD34)19’2 Indium CI3 (2 mCi in 0.2 ml sterile pyrogen
and the mucosal vascular addressin MadCAM- free 0.04 N hydrochloric acid) and 25I-human
1.
21 These ligands are mainly present on lymph- serum albumin (50 #Ci/20 mg albumin/ml ster-
oid endothelial cells. The exact inducible ligand ile pyrogen free isotonic saline) were from
for L-selectin on endothelial cells of postcapil- Amersham International (Buckinghamshire,
lary venules is until now not known. Heparin- UK). Percoll was from Pharmacia Fine Chemi-
like ligands for L-selectin are demonstrated on cals (Uppsala, Sweden). Plasmasteril (6% hydrox-
non-lymphoid endothelial cells,
22 supporting yethyl starch in 0.9% NaC1, sterile pyrogen
the predicted anionic, carbohydrate nature act- free) was from Fresenius A.G. (Homburg, Ger-
ing as ligand for the lectin domain of L-selectin. many). Sterile pyrogen-free solution of acid-
The importance of carbohydrate glycans in citrate-dextrose (ACD) was from Baxter (Les-
mediating selectin-dependent leukocyte adhe- sines, Belgium).
sion and emigration has been shown using a Sodium pentobarbitone (Nembutal@, 60 mg/
variety of polysaccharide structures: including ml) was from Abbott (Paris, France). Human
(i) the inhibition of P-selectin-mediated PMN recombinant interleukin lfi (IL-1)was supplied
adhesion in vitro by dextran sulphate, heparin by NIH (Maryland, USA) and human recombi-
and fucoidan; (ii) the inhibition of leukocyte nant IL-8 was purchased from R&D Systems
rolling in rats and rabbits by fucoidan, dextran (Minneapolis, USA). LTB4 was purchased from
sulphate and heparin and (iii) the reduced PMN Cayman Chemical Co. (Ann Arbor, Michigan,
accumulation in cerebrospinal fluid in pneumo- USA). Histamine.2HC1 was from Pharmachemic
coccal antigen treated rabbits by fucoidan.2-26 (Antwerp, Belgium). Zymosan-activated plasma
In general PMN recruitment into tissue may (ZAP), used as a source for C5a desArg, was
be directed by different adhesion pathways prepared by incubating heparinized rabbit plas-
depending on the type of the inflammatory ma with zymosan 5 mg/ml for 30min at 37C.
agent. In the present study we have evaluated Zymosan was removed by centrifugation
the effect of various sulphated polysaccharides (3 500 rpm, 0C). The concentration of C5a
on PMN extravasation and plasma leakage in desArg in ZAP was 470 nM as determined by
response to different types of inflammatory radioimmunoassay.
27
mediators. PMN accumulation and oedema for- R15.7 (a murine monoclonal antibody (mAb)
mation were measured in a rabbit skin model of (IgG)) directed against the common CD18-
acute inflammation as the local accumulation of integrin) was kindly provided by Dr R. Rothlein,
In-labelled PMNs and 25I-albumin after intra- Boehringer Ingelheim Pharmaceuticals, Inc.
dermal injection of various inflammatory media- (Ridgefield, Connecticut, USA). Mouse IgG, pur-
tors. Different types of inflammatory agents chased from Sigma, was administered as control
were injected: PMN chemoattractants (FMLP, immunoglobulin.
C5a desArg, LTB4 and IL-8), inducing PMN Different sulphated polysaccharides were
extravasation and a parallel increase in vascular tested: dextran sulphate (mol. wt. 500 000) was
permeability; ILl evoking PMN recruitment from Pharmacia LKB (Uppsala, Sweden). The
without plasma leakage via a protein synthesis- non-sulphated analogue dextran T500, with
dependent mechanism, and the permeability identical molecular weight was used as control.
increasing agents histamine and thrombin gen- Heparin (porcine intestinal mucosa, grade II,
erating plasma leakage not associated with PMN 151 U/mg) was purchased from Sigma Chemical
emigration. Co. (St Louis, MO, USA). Fucoidan, a fucose-4
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sulphate-rich polysaccharide derived from Fucus
vesiculosus, and protamine sulphate were ob-
tained from Sigma Chemical Co. All polysacchar-
ides were dissolved in sterile, pyrogen free salt
solution (0.9%) and passed through a 0.2 ktM-
sterile filter before intravenous administration.
All solutions were made immediately before the
start of the experiment.
Preparation of 111In-labelled PMNs
Isolation and labelling with lllin_radioisotopes
of rabbit PMNs were executed as previously
described.28’29 Briefly, 72 ml of citrated blood
was collected after cannulation of the carotid
artery from an anaesthetized donor rabbit.
PMNs were purified by a 40-60% discontinuous
Percoll-plasma gradient, after initial red cell
sedimentation with hydroxyethylstarch (Plas-
masteril, final concentration 3%). PMNs (4-
7 107 cells) were incubated with llllnC13
(50-200 tCi) chelated to MERC (40 g) for
15 min at room temperature. The labelled cells
were washed twice and resuspended in 6 ml
autologous citrated plasma before intravenous
injection into two recipient rabbits.
For ex vivo incubation with dextran sulph-
ate,l11In-PMNs were divided into two equal
amounts of cells (approximately 3 10v cells/
tube) before the last wash. The cells were
incubated with 5 mg of dextran sulphate or
dextran T500 (as control) for 15 min in a total
volume of 1 ml. Thereafter, PMNs were washed
with autologous citrated plasma and injected
into two recipient rabbits.
Estimation of PMN accumulation and
plasma leakage in rabbit skin
Rabbits were anaesthetized with sodium pento-
barbital (30mg/kg) and the back skin was
clipped. PMN infiltration and plasma leakage
were measured as the local accumulation of
intravenously (i.v., 15 min) injected In-la-
belled PMNs and 125I-human serum albumin
(5/,Ci mixed with 2 ml of a 2.5% Evans blue
dye solution to visualize sites of plasma protein
leakage). Inflammatory mediators were injected
intradermally (i.d.) in 0.1 ml volumes (diluted in
sterile pyrogen-free saline), each agent having
six replicate injection sites per animal (accord-
ing to a balanced site pattern).
Different inflammatory mediators were tested
in the rabbit skin: a protein synthesis-dependent
mediator: IL-1 (20-200U/site); PMN chemo-
attractants: FMLP (5.10-12-5.10-11 mol/site),
C5a desArg (5.10-12-5.10-11mol/site), LTB4
(5.10-11-5.10-1 mol/site) and IL-8 (2.10-12-
2.10-11 mol/site); and PMN-independent, micro-
vascular permeability increasing mediators: his-
tamine (Hist, 10-8 mol/site) and thrombin (Thr,
1 U/site).
PMN infiltration and oedema formation in the
rabbit skin are based on a synergism between
an increase in local blood flow on the arteriolar
side and an increase in vascular permeability on
the venular side. Therefore calcitonin gene-
related peptide (CGRP, 10-11 mol/site) was co-
injected as vasodilator together with the inflam-
matory agents to increase the low basal blood
flow in the back skin of the rabbit.
In all in vivo experiments ’t-----0’ refers to the
i.d. injection of various inflammatory mediators
plus CGRP. IL-1 acting via a protein synthesis-
dependent mechanism, was injected 3.5 h be-
fore the other inflammatory agents and before
CGRP, in order to get a maximal response.
28
After measuring PMN accumulation and plas-
ma leakage over a period of 1 h, a blood sample
was taken by cardiac puncture. Rabbits were
killed by an overdose of sodium pentobarbital
and the injection sites were excised with a
17 mm diameter punch. The skin samples were
counted in a gamma-counter with automatic
spill-over correction (Cobra 5005, Packard).
PMN infiltration is expressed as the number of
1111n-PMNs/site determined by comparing
11 lin.
counts per site with IllIn-counts per PMN after
labelling. Plasma extravasation is expressed in
terms of equivalents of tl plasma by dividing
skin sample 125I-counts by 25I-counts in 1/,1
plasma. Calculation of the percentage of circu-
lating radiolabelled PMNs at the end of the
experiment was based on total cell-associated
activity injected and total blood volume of the
recipient rabbit (7.4% expressed as percentage
of the body weight).
PMN aggregation
Human PMNs were isolated from 15 ml of buffy
coats (obtained from the Antwerp Transfusion
Centre, Belgium) by a discontinuous Percoll-
Hank’s/BSA gradient, after red cell sedimenta-
tion with 3% hydroxyethylstarch. Cells were
suspended in Hank’s Balanced Salt Solution (1%
BSA) at concentrations of 2 107 cells/ml. Ag-
gregometry was performed using a Payton Dual
Channel Standard platelet aggregometer, with
minor modifications.2
Two hundred ,ul of the PMN suspension was
added to a siliconized cuvette with a Teflon
stirring bar revolving at 600 rpm. Ca2//Mg2+
(0.5 mM as a final concentration) and cytochala-
sin B (Cyt B, 10 ktg/ml) was added to the cells
after warming up to 37C during 1 min. After
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addition of FMLP (10-6 M) the resulting changes (t- -3.5 h). Although the polysaccharide still
in light transmission were recorded in function reduced the FMLP-induced PMN infiltration and
of time. Test agents were added 1 min prior to plasma leakage 3.5 h later, it did not affect the
the addition of Ca2+/Mg2+. All worldng solu- IL-1 mediated responses (Fig. 2).
tions were made in Hank’s Balanced Salt Solu- Interference of dextran sulphate at the level
tion with 1% BSA. of chemoattractant/receptor interaction is un-
likely, since local administration of dextran sul-
Statistics phate (1-100/g/site) together with FMLP or
histamine did not inhibit plasma leakage (data
All data are reported as the mean 4- standard not shown).
error of the mean (SEM) for the indicated The direct effect of dextran sulphate on PMNs
number of experiments and have been analysed was also investigated. In these experiments,
using a Student’s t-test for unpaired investiga-
illIn-labelled PMNs were incubated ex vivo
tions. Statistical significance was set at with dextran sulphate (5 mg) or dextran T500
p < 0.05. (control) before i.v. injection of the PMNs. As
shown in Table 1, ex vivo incubation of ]11In-
PMNs with dextran sulphate did not suppress
Results PMN infiltration. The lack of effect of dextran
sulphate on PMN extravasation after ex vivo Effect of dextran sulphate, heparin or
fucoidan on PMN infiltration and incubation may correspond with the reversible
binding of dextran sulphate to PMNs. plasma leakage In comparison to dextran sulphate a higher
In control-treated animals (dextran T500, dose of heparin was needed to inhibit leukocyte
25 mg/kg), PMN accumulation and plasma leak- rolling.34 The dose of heparin (90 mg/kg),
age dose-dependently increased after local injec- which was required to inhibit leukocyte rolling
tion of the PMN chemoattractants FMLR C5a for >90%, was not sufficient to significantly
desArg, LTB4 and IL-8 (Fig. 1). PMN infiltration suppress PMN infiltration in the rabbit skin
induced by IL-1 was not associated with detect- measured over a period of 1 h (data not shown).
able oedema formation. Histamine and throm- Therefore two bolus injections of heparin
bin evoked an increase in microvascular plasma (90 mg/kg) were injected i.v. (15 rain before
leakage without a significant increase in PMN and 15 min after i.d. injection of the inflamma-
accumulation. Intravenous injection of dextran tory agents). As shown in Fig. 3, this dose of
sulphate (25 mg/kg, 30 rain before the start of heparin resulted in a significant but incomplete
the experiment), completely abolished PMN inhibition of PMN infiltration and plasma leak-
infiltration and plasma extravasation in response age induced by the PMN chemoattractants.
to the PMN chemoattractants. This concentra- PMN recruitment in response to IL-1 was not
tion of dextran sulphate had been shown to significantly suppressed. Again plasma leakage
inhibit leukocyte rolling in rabbit mesenteric induced by histamine and thrombin was not
venules for more than 90%.
24 In contrast, PMN affected.
accumulation in response to IL-1 was not The ligand activity of fucoidan for L-selectin
suppressed by dextran sulphate and it did not was described to be at least 100-fold more
affect the PMN-independent increase in vascular potent per unit weight than heparin.
35 There-
permeability induced by histamine and throm- fore, 1 mg/kg fucoidan was injected 15 rain
bin. The inhibition of PMN extravasation by before the start of the experiment. This dose of
dextran sulphate was not due to an effect on fucoidan significantly inhibited PMN infiltration
the circulating number of In-labelled PMNs for 60-70% (after background substraction)and
measured at the end of the experiments (dex- oedema formation for 50-60% in response to
tran sulphate" 51 4- 3% vs dextran T500: the chemoattractants (Fig. 4). In contrast to the
49 + 3%). results obtained after administration of dextran
IL-1 was injected i.d. 3.5 h before the other sulphate or heparin, fucoidan also reduced PMN
inflammatory mediators and before CGRP recruitment after IL-1 injection. Fucoidan did
(10-11 mol/site), but also 3 h before the intra- not affect the percentage of circulating In-
venous injection of dextran sulphate. To ex- PMNs as measured at the end of the experiment
clude the possibility that a time-related (fucoidan" 48 -+- 8% vs control: 54 -+- 8%).
phenomenon could be responsible for the lack Protamine sulphate (i.v., 25 mg/kg), also
of effect of dextran sulphate on the IL-l-induced shown to inhibit leukocyte rolling in mesenteric
PMN infiltration, dextran sulphate was also postcapillary venules,4 could not be admin-
injected just before the i.d. injection of IL-1 istered in this model since systemic administra-
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FIG. 1. Effect of dextran sulphate (25 mg/kg, -30 min, B) vs dextran T500 (25 mg/kg, O) on PMN recruitment (expressed as
1111n-PMNs/site) (panel A) and plasma albumin leakage (expressed as ,ul plasma/site) (panel B). IL-1, FMLP, C5a desArg,
LTB4, IL-8, Hist and Thr were injected i.d. in the presence of CGRP (10-11 mol/site). The dashed line represents the response
to i.d. injection of saline. The results are expressed as the mean -I- SEM for n-- 7 rabbits (* p < 0.01, Student’s t-test: dextran
sulphate vs dextran T500).
tion resulted in a dramatic decrease of the mean
arterial blood pressure in the rabbit (data not
shown).
IL-l-induced PMN accumulation was suppressed
for 60-70% in anti-CD18 treated animals. Plas-
ma leakage induced by thrombin was not
affected.
Estimation of CD18-mediated PMN
infiltration in rabbit skin
Anti-CD18 (R15.7, 2 mg/kg) or mouse IgG
(2 mg/kg) were injected i.v. 30 min before the
start of the experiment (Fig. 5). PMN infiltration
and plasma leakage in response to the PMN
chemoattractants C5a desArg, FMLP, LTB4 and
IL-8 were completely suppressed by anti-CD18.
Effect of dextran sulphate on FMLP-
induced PMN aggregation
PMNs were incubated with dextran sulphate or
dextran T500 (final concentration 300 tg/ml)
during 1 min at 37C, under stirring conditions.
This in vitro concentration is comparable with
the in vivo injected dose of 25 mg/kg, taken
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FIG. 2. PMN infiltration (1111n-PMNs/site, panel A) and oedema formation (/1 plasma/site, panel B) measured in rabbits after
systemic administration of dextran sulphate (25 mg/kg, ) or dextran T500 (25 mg/kg, (C)) 3.5 h prior to the start of the
experiment. Results are expressed as the mean -t- SEM for n--4 rabbits (* p< 0.01, Student’s t-test: dextran sulphate vs
dextran T500).
into account that the blood volume in the rabbit
is about 7.4% of its body weight.
31 After
recalcification (Ca2+/Mg2+, 0.5 mM) and addi-
tion of Cyt B (10 g/mD, PMNs were stimulated
with FMLP (10-6 M). As shown in Fig. 6, PMN
aggregation in the presence of dextran T500
(300 #g/ml) was not altered as compared to
control aggregation. Although the maximal ag-
gregation was not altered in the presence of
dextran sulphate, the aggregation was delayed.
Similar results were obtained with heparin (data
not shown). In contrast, fucoidan (20 g/mD
had no effect on PMN aggregation. Under the
same experimental conditions, anti-CD18 sup-
pressed PMN aggregation by more than 70% (R
15.7 10/Jg/ml, vs mouse IgG).
Discussion
Rolling of leukocytes along endothelial cells is
mediated by various selectins: L-selectin on
leukocytes and P- and E-selectin on activated
endothelial cells. All three selectins are recog-
nizing carbohydrate-based ligands on opposing
cells via their Ca2+-dependent lectin domain,
with a common recognition motif sialyl Lewis x
(SLeX).6 Sulphated polysaccharides, like dextran
sulphate and fucoidan can disturb selectin-
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Table 1. Effect of ex vivo incubation of 1111n-PMNs with dextran sulphate (5 mg) or
dextran T500 on PMN accumulation (expressed as 1111n-PMNs/site) in vivo
Mediator Concentration 1111n-PMNs/site
Dextran T500 Dextran sulphate
IL-1 200 U/site 2459 4- 193 2172 4- 441
FMLP 5 x 10-1 mol/site 3378 -t- 216 3010 4- 756
C5a desArg 5 10-
mol/site 3029 4- 274 2613 -I- 411
CGRP 10-1 mol/site 611 + 66 540-t- 11
The results are expressed as the mean 4- SEM for n 5 rabbits. All mediators were tested in the
presence of CGRP (10
-11 mol/site) as vasodilator.
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FIG. 3. Effect of two bolus injections of heparin (90mg/kg, 15min before and 15min after i.d. injection of PMN
chemoattractants plus CGRP) (closed bars) vs saline (open bars) on PMN infiltration (panel A) and plasma leakage (panel B).
Results are expressed as the mean 4- SEM for n- 7 rabbits (* p <. 0.05, Student’s t-test: heparin vs saline).
mediated rolling of PMNs along the endothelial
2425 cells in postcapillary venules. In our rabbit
skin model of acute inflammation dextran sul-
phate selectively inhibited PMN infiltration and
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associated plasma leakage in response to intra-
dermal injection of various PMN chemoattrac-
tants (FMLP, C5a desArg, IL-8 and LTB4), with-
out suppressing IL-l-induced PMN infiltration.Sulphatedpolymers andPMN extravasation
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FIG. 4. PMN infiltration (panel A) and oedema formation (panel B) in response to different inflammatory mediators, after i.v.
injection of fucoidan (1 mg/kg, -15 min, m) vs control (saline, ml/kg, (C)). Results are expressed as the mean 4- SEM for
n 5-7 rabbits (* p < 0.05, Student’s t-test: fucoidan vs saline).
Since the increase in vascular permeability in
response to histamine and thrombin was not
affected by dextran sulphate, we can exclude
possible dextran sulphate-induced changes in
local blood flow. The complete inhibition of
PMN infiltration by dextran sulphate was com-
parable with the more than 90% reduction of
leukocyte rolling in rabbit mesentery venules,
obtained by Ley et al.24 The presence of
sulphate on glycans is crucial since other
negatively charged or neutral po!ysaccharides
had no effect on leukocyte rolling.4
The possible involvement of sulphated glyco-
conjugates during leukocyte-endothelial cell
interaction is demonstrated at different levels.
The interaction of sulphated and phosphated
polysaccharides (i.e. dextran sulphate, fucoidan
and PPME (a yeast polysaccharide of mannose
and mannose-6-phosphate) with L-selectin has
been demonstrated in vitro and suggested in
ViVO.37-39 Rapid sulphate uptake by high en-
dothelial cells in the venous microvasculature is
correlated with increased lymphocyte accumu-
lation, most likely mediated by the homing
receptor L-selectin.8’4 An internal pool of he-
parin-like chains, recognizing L-selectin was
found in cultured venular endothelial cells.
22
The sulphatation of the endothelial cell ligand
Gly-CAM-1 was demonstrated to be essential for
41 the binding to L-selectin. The sulphated form
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FIG. 5. Inhibition of PMN infiltration (panel A) and plasma leakage (panel B) in rabbit skin after administration of anti-CD18
(2 mg/kg, closed bars) vs mouse IgG as control (2 mg/kg, hatched bars). PMN infiltration and plasma leakage in response to
i.d. injection of IL-1, C5a desArg and thrombin are shown. Similar results as for C5a desArg were obtained after i.d. injection
of the other PMN chemoattractants (FMLP, LTB4 and IL-8). Results are expressed as the mean +/- SEM for n=4 rabbits
(* p < 0.05, Student’s t-test: anti-CD18 vs mouse IgG).
120-
100
80
60
40
20
o &
Time (min)
FIG. 6. Effect of dextran sulphate (300/g/ml, ,) or dextran
T500 (300/g/ml, A) and fucoidan (20/g/ml, T, on PMN
aggregation, measured as percentage change in light
transmission vs control ((C)). Anti-CD18 (R15.7, 10/g/ml) (0)
was added to investigate CD18-dependent aggregation.
Results are expressed as the mean percentage change in
light transmission + SEM (n-5-7) (* p< 0.05, Student’s t-
test: dextran sulphate vs dextran T500).
of SLex (6’-sulphated SLeX), capping the Gly-
CAM-1 structure, binds to L-selectin with higher
affinity than SLeX.42 Tyrosine sulphatation of the
P-selectin glycoprotein ligand-1 (PSGL-I) struc-
ture is in addition to the appearance of fucosy-
lated, sialylated glycans important for the
binding of P-selectin but of no importance for
43 the recognition of E-selectin.
Inhibition of PMN infiltration after administra-
tion of heparin was similar to the effect of
dextran sulphate, although less pronounced.
The lower potency of heparin to reduce PMN
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extravasation is consistent with its lower po-
tency to block leukocyte rolling.4 Administra-
tion of high doses of heparin as anti-
inflammatory agent may be irrelevant, because
of its strong anticoagulant activity. Recently,
heparin oligosaccharides without significant anti-
coagulant activity have been demonstrated to
inhibit P- and L-selectin-dependent PMN infiltra-
tion in a murine model of thioglycollate-induced
peritoneal inflammation.s
In contrast to dextran sulphate, fucoidan
(1 mg/kg) not only suppressed PMN and plasma
protein accumulation in response to PMN
chemoattractants but also attenuated IL-l-in-
duced PMN recruitment for about 60-70%. It is
important to know that fucoidan had no effect
on the number of circulating PMNs. Similar
results were obtained by Lindbom et al. in rat
mesenteric microvessels using intravital micro-
scopy.
44 They achieved a 70% inhibition of
leukocyte adhesion, via a rolling-dependent,
CD11/CD18-independent mechanism after ad-
ministration of 1 mg/kg of fucoidan. Fucoidan
has been demonstrated to attenuate leukocyte-
and plasma protein extravasation into cere-
brospinal fluid of rabbits challenged with pneu-
mococcal antigen.
26
Our in vivo results have shown a different
inhibitory pattern of fucoidan and dextran
sulphate for IL-l-induced PMN accumulation.
The exact mechanism is until now not known.
Different adhesion pathways or different bind-
ing sites may be the reason for a complete
inhibitory effect by fucoidan and only a partialSulphatedpolymers andPMN extravasation
reduction after administration of dextran sul- dextran sulphate at the PMN surface or due to
phate. IL-l-activated venular endothelium may an interference on the lectin-dependent PMN
express a ligand for L-selectin with binding aggregation.
characteristics different from that expressed All three selectins are possible candidates to
after administration of PMN chemoattractants, interact with the sulphated polysaccharides.
This ligand may be E-selectin, as suggested by Differential involvement of P- and E-selectin in
Kishimoto et al.,45 or a new until now not well addition to L-selectin may be important in PMN
defined, inducible ligand as demonstrated by recruitment in rabbit skin after injection of
Spertini et al.
46 Differences in binding to L- PMN chemoattractants or IL-1. E-selectin med-
selectin have been described for PPME and iates leukocyte rolling in IL-l-treated rabbit
fucoidan.7 Both PPME and fucoidan are able to mesentery venules.15 A cytokine-inducible li-
block L-selectin-mediated murine lymphocyte gand for L-selectin is described on nonlymphoid
and PMN adhesion to lymph node high en- cells.
22 P-selectin is translocated within minutes
dothelial venules (HEV) in vitro, but only to the cell surface after stimulation with throm-
fucoidan is capable to inhibit L-selectin- bin, histamine or oxygen radicals.
1 Recently a
mediated leukocyte rolling in venules of rat cytokine upregulation of P-selectin with a time
mesentery.
25 Nevertheless identical binding course similar to that of E-selectin expression
characteristics to P- and L-selectin were de- was also found.51’52
scribed for fucoidan and dextran sulphate, Participation of P-selectin in PMN infiltration
47 48 whereas no binding was found to E-selectin. in response to the different inflammatory media-
In contrast to identical binding characteristics, tots in this skin model is still a question mark.
functional differences between fucoidan and The sulphated polysaccharides, like dextran
dextran sulphate were found after in vitro sulphate, heparin and fucoidan are shown to
incubation of PMNs followed by stimulation, disrupt P-selectin-mediated PMN interaction in
The rate and extent of formyl-peptide-induced vitro. 3,53 Until now, there is no direct evidence
L-selectin shedding is consistently reduced after to suggest that P-selectin is expressed on
treatment of PMNs with fucoidan as compared endothelial cells after stimulation with pure
with dextran sulphate-treated PMNs.49 PMN chemoattractants such as FMLP or IL-8.
It is unlikely that the sulphated polysacchar- Under those conditions histamine is not re-
ides are acting on the level of the PMN /2- leased as secondary mediator in response to IL-
integrins (CD11/CD18). As demonstrated by Ley 1 or PMN chemoattractants.54 In our model the
et al., dextran sulphate up to concentrations of sulphated polysaccharides had no effect on
1 mg/ml did not alter CD1 lb/CD18 expres- histamine- or thrombin-related increase in mi-
sion.3 Furthermore, both fucoidan and dextran crovascular permeability. Nevertheless, neuro-
sulphate failed to inhibit CD1 lb/CD18-depen- peptides such as calcitonin gene-related peptide
dent PMN adhesion under stationary conditions (CGRP), locally injected in normal human skin,
in vitro.33’44 In addition, selectin-mediated roll- translocate P-selectin within 15 min to the
ing of leukocyte is blocked by sulphated poly- luminal membrane.55 Since in our model CGRP
saccharides, whereas anti-CD18 antibodies had is co-injected to enhance the local blood flow,
no effect.1’5 In our model dextran sulphate did the role of P-selectin during PMN infiltration
not inhibit IL-l-induced PMN accumulation, can therefore not be excluded.
whereas monoclonal antibodies against CD18 The relative role of the selectins may depend
reduced PMN accumulation in response to IL-1 on the particular mediators and on the inflam-
in this rabbit skin model. A non-specific in- matory model being studied. The selectin-
crease in charge density on the PMN-surface by mediated adhesion pathways of leukocytes on
dextran sulphate is unlikely to be the cause of endothelial cells are partially redundant, par-
the inhibition, because a similar inhibitory tially separate.56’57 The combined involvement
effect of dextran sulphate would then be of different selectins was demonstrated in vivo
expected after IL-1 injection. CD18-dependent by Mulligan in two models of lung inflammation
PMN aggregation induced by FMLP was delayed using selectin antibodies. Acute lung injury
in the presence of dextran sulphate, however induced by Cobra Venom Factor, measured after
not suppressed. In contrast, fucoidan had no 30 min, was mediated by both L- and P-selectin,
attenuating effect on PMN aggregation. Our whereas IgG immune complex-induced injury,
results are in agreement with the observations measured after a period of 4 h was L- and E-
of Bazzoni et al., who found a reduced PMN selectin-dependent.
58 Recent studies on animals
aggregation in the presence of heparin mea- genetically deficient in these selectin have shed
sured at 3 min after stimulation3 The delay in light on the temporal sequence of selectin
aggregation may be due to sterical hindrance of functions, as well as on their individual con-
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tributions in acute inflammatory models.59 Early
after injury leukocyte rolling was defective and
PMN emigration was delayed in P-selectin
knock-out mice, whereas later on L-selectin-
mediated rolling appeared to be more
prominent.56’6 Discrimination between the dif-
ferent selectins can also be made on the level of
oedema formation. In a model of contact-
hypersensitivity plasma leakage was increased
via a L-selectin-dependent mechanism with only
a minor role for P-selectin.61’62 Which adhesion
pathways are involved during PMN recruitment
evoked by the chemoattractants and by IL-1 in
the rabbit skin is at present not clear. Different
infiltration pathways in response to IL-1 or to
the chemoattractant FMLP were also demon-
strated by Wakelin et al.63 With mAb against
PECAM-1 IL-l-induced PMN extravasation across
rat mesenteric microvessels could be sup-
pressed, whereas anti-PECAM-1 had no effect on
FMLP-evoked PMN infiltration. There is, how-
ever, no evidence that dextran sulphate or
fucoidan can interfere with the PECAM-1 adhe-
sion pathway.
The exact mechanism behind the inhibition
of PMN infiltration and oedema formation by
the sulphated polysaccharides is not clear. It
cannot be excluded that dextran sulphate and
heparin might interfere with PMN-derived poly-
cations, such as elastase, cathepsin G or defen-
sins to reduce PMN recruitment.64’65 However,
the direct inhibition of elastase by dextran
sulphate is unlikely, since LTB4-induced PMN-
dependent increase of plasma leakage in the
hamster cheek pouches was significantly sup-
pressed by dextran sulphate, whereas adminis-
tration of elastase inhibitors had no effect.65 The
role of other naturally occurring cationic pep-
tides, derived from PMNs, dnring the induction
of plasma leakage cannot, however, be ex-
cluded.
Nevertheless, since the recent selectin-carbo-
hydrate binding studies, there is increasing and
attractive evidence to suggest that the anti-
infiltrating properties of these sulphated poly-
saccharides are attributed to their interference
with the selectins.25’38 Although the different
selectin adhesion molecules can commonly bind
to SLex and related compounds, the knowledge
of the specific binding characteristics of the
carbohydrate structure with each selectin, can
contribute to a more efficient anti-adhesion
therapy.
We have demonstrated that sulphated glycans
may be involved during PMN infiltration and
plasma leakage in the rabbit skin unrelated to
the CD1 lb/CD18 adhesion pathway. Since dex-
tran sulphate and fucoidan differently inhibit
PMN infiltration in vivo, depending on the type
of inflammatory stimulus, different sulphated
glycans may be involved during PMN recruit-
ment.
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